These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33981654)

  • 1. Clinicopathological Analysis of 34 Cases of Primary Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Chinese Children.
    Wu J; Pei Y; Rong L; Zhuang H; Zeng S; Chen L; Jiang X
    Front Pediatr; 2021; 9():656307. PubMed ID: 33981654
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and Renal Histology Findings and Different Responses to Induction Treatment Affecting the Long-Term Renal Outcomes of Children With ANCA-Associated Vasculitis: a Single-Center Cohort Analysis.
    Yang J; Yang Y; Xu Y; Zhou L; Zhou L; Yin X; Pu J; Yang F; Liu Y; He Y; Chen Y; Yuan H; Qiu L; Zhang Y; Chen Y; Liu T; Tang J; Zhou J
    Front Immunol; 2022; 13():857813. PubMed ID: 35493514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for renal outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis: a nationwide retrospective study in China.
    Tan LW; Wan JL; Zhu CH; Xu H; Xia ZK; Chen LZ; Wu XC; Wang F; Liu XR; Zhao CG; Li XZ; Mao JH; Wang XW; Huang WY; Li YH; Zhang JJ; Feng SP; Yang J; Liu JJ; Gao CL; Rong LP; Shuai LJ; Xu K; Zhang HJ; Li Q; Zhang AH; Wang M
    World J Pediatr; 2024 May; 20(5):506-516. PubMed ID: 37853276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the risk factors for end‑stage renal disease and mortality in ANCA-associated vasculitis: a study from a single center of the Chinese Rheumatism Data Center.
    Guo Q; Yu L; Zhang X; Shang J; Duan X
    Clin Rheumatol; 2023 Feb; 42(2):489-499. PubMed ID: 36367596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study.
    Sacri AS; Chambaraud T; Ranchin B; Florkin B; Sée H; Decramer S; Flodrops H; Ulinski T; Allain-Launay E; Boyer O; Dunand O; Fischbach M; Hachulla E; Pietrement C; Le Pogamp P; Stephan JL; Belot A; Nivet H; Nobili F; Guillevin L; Quartier P; Deschênes G; Salomon R; Essig M; Harambat J
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i104-12. PubMed ID: 25676121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of renal outcomes in anti-neutrophil cytoplasmic antibody glomerulonephritis.
    Jebali H; Khadhar M; Mami I; Beji S; Sellami M; Hassen M; Hmida FB; Chermiti M; Ghabi H; Salem TB; Houman H; Raies L; Zouaghi MK
    Saudi J Kidney Dis Transpl; 2020; 31(1):182-190. PubMed ID: 32129212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retrospective clinical features and renal pathological analysis of 15 children with anti-neutrophil cytoplasmic antibody-associated vasculitis].
    Guan N; Yao Y; Yang JY; Xiao HJ; Ding J
    Zhonghua Er Ke Za Zhi; 2013 Apr; 51(4):283-7. PubMed ID: 23927802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis.
    Özçelik G; Sönmez HE; Şahin S; Özağarı A; Bayram MT; Çiçek RY; Çakıcı EK; Çomak E; Barut K; Şahin N; Bakkaloğlu S; Gökçe İ; Düzova A; Bilginer Y; Açarı C; Melek E; Kılıç BD; Özdel S; Adroviç A; Kasapçopur Ö; Ünsal E; Alpay H; Orhan D; Topaloğlu R; Düşünsel R; Özen S
    Pediatr Nephrol; 2019 May; 34(5):847-854. PubMed ID: 30607566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
    Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective analysis of antineutrophil cytoplasmic antibody-associated vasculitis aiming for an equation prediction end-stage renal disease.
    Kim MK; Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2022 Mar; 41(3):773-781. PubMed ID: 34750691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relation between histopathological classification and renal outcome, ANCA subtype and treatment regimens in ANCA-associated vasculitis.
    Kristensen T; Gregersen JW; Krag SR; Ivarsen P
    Clin Exp Rheumatol; 2016; 34(3 Suppl 97):S105-10. PubMed ID: 27241586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinuria Indicates Decreased Normal Glomeruli in ANCA-Associated Glomerulonephritis Independent of Systemic Disease Activity.
    Tampe D; Korsten P; Ströbel P; Hakroush S; Tampe B
    J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33917561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential Therapy for Remission Induction in Severe Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis.
    Kant S; Habbach A; Gapud EJ; Manno RL; Gattu R; Seo P; Geetha D
    Am J Nephrol; 2019; 50(5):386-391. PubMed ID: 31593967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
    Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
    Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and clinical features of childhood-onset anti-neutrophil cytoplasmic antibody-associated vasculitis: a clinicopathological analysis.
    Hirano D; Ishikawa T; Inaba A; Sato M; Shinozaki T; Iijima K; Ito S
    Pediatr Nephrol; 2019 Aug; 34(8):1425-1433. PubMed ID: 31076873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
    Iwakiri T; Fujimoto S; Kitagawa K; Furuichi K; Yamahana J; Matsuura Y; Yamashita A; Uezono S; Shimao Y; Hisanaga S; Tokura T; Wada T; Kitamura K; Asada Y
    BMC Nephrol; 2013 Jun; 14():125. PubMed ID: 23773275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathological characteristics of ANA/anti-dsDNA positive patients with antineutrophil cytoplasmic autoantibody-associated vasculitis.
    Zhao X; Wen Q; Qiu Y; Huang F
    Rheumatol Int; 2021 Feb; 41(2):455-462. PubMed ID: 32964277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent hematuria in patients with antineutrophil cytoplasmic antibody-associated vasculitis during clinical remission: chronic glomerular lesion or low-grade active renal vasculitis?
    Lv L; Chang DY; Li ZY; Chen M; Hu Z; Zhao MH
    BMC Nephrol; 2017 Dec; 18(1):354. PubMed ID: 29207950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANCA-associated nephritis without crescent formation has atypical clinicopathological features: a multicenter retrospective study.
    Zoshima T; Suzuki K; Suzuki F; Hara S; Mizuguchi K; Ito K; Mizushima I; Fujii H; Nomura H; Kawano M
    Clin Exp Nephrol; 2020 Nov; 24(11):999-1006. PubMed ID: 32651749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Microscopic Hematuria after Induction of Remission in Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis.
    Vandenbussche C; Bitton L; Bataille P; Glowacki F; Azar R; Hatron PY; Macnamara E; Gheerbrant JD; Cardon G; Hoffmann M; Auxenfants E; Gnemmi V; Quéméneur T
    Am J Nephrol; 2019; 49(6):479-486. PubMed ID: 31117066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.